Image

North America Laxative Market – Industry Trends and Forecast to 2031

Pharmaceutical

Image

North America Laxative Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Upcoming Report
  • Jun 2024
  • North America
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

North America Laxative Market – Industry Trends and Forecast to 2031

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2023–2031
Diagram Market Size (Base Year) USD 4.31 USD Billion
Diagram Market Size (Forecast Year) USD 6.72 USD Billion
Diagram CAGR %

Major Markets Players

  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline plc
  • Bayer AG
  • Fresenius Kabi Austria GmbH
  • Prestige Consumer Healthcare

North America Laxative Market, By Type (Osmotic laxatives, Stimulant laxatives, Bulk laxatives and Lubricant and Emollient laxatives), Flavors (With Flavor and Without Flavor), Source (Natural, Synthetic and Others), Indication (Chronic Constipation, irritable bowel Syndrome with Constipation, Opioid-Induced constipation, Acute constipation and Others), Mode of Purchase (Prescription and Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid and Gels, Suppositories and Others), Route of Administration (Oral and Rectal), Population Type (Children and Adults), Sales Channel (Hospitals, Elderly Care Centers, Home Healthcare, Pharmacy Stores, grocery/Health and Beauty Stores and Others), Distribution channel (Direct Sales, Wholesalers and Others) – Industry Trends and Forecast to 2031.

North America Laxative Market

 

North America Laxative Market Analysis and Size

Laxatives are used to manage symptoms of Irritable Bowel Syndrome with Constipation (IBS-C), a type of irritable bowel syndrome characterized by constipation. The laxative market has a significant application in IBS-C, as it helps alleviate symptoms such as difficult and infrequent bowel movements. The increasing prevalence of IBS-C, particularly among adults, drives the demand for laxatives in this indication. Laxatives are prescribed to manage IBS-C symptoms, including constipation, bloating, and abdominal pain. The market for laxatives in IBS-C is driven by the growing awareness of gastrointestinal disorders and the need for effective treatments to manage these symptoms.

North America laxative market size was valued at USD 4.31 billion in 2023 and is projected to reach USD 6.72 billion by 2031, with a CAGR of 5.70% during the forecast period of 2024 to 2031.

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation       

Report Metric

Details

Forecast Period

2024-2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Osmotic laxatives, Stimulant laxatives, Bulk laxatives and Lubricant and Emollient laxatives), Flavors (With Flavor and Without Flavor), Source (Natural, Synthetic and Others), Indication (Chronic Constipation, irritable bowel Syndrome with Constipation, Opioid-Induced constipation, Acute constipation and Others), Mode of Purchase (Prescription and Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid and Gels, Suppositories and Others), Route of Administration (Oral and Rectal), Population Type (Children and Adults), Sales Channel (Hospitals, Elderly Care Centers, Home Healthcare, Pharmacy Stores, grocery/Health and Beauty Stores and Others), Distribution channel (Direct Sales, Wholesalers and Others)

Countries Covered

U.S., Canada, and Mexico

Market Players Covered

Boehringer Ingelheim International GmbH (Germany), GlaxoSmithKline plc (U.K.), Bayer AG (Germany), Fresenius Kabi Austria GmbH (Austria), Prestige Consumer Healthcare Inc. (U.S.), Procter & Gamble (U.S.), Sun Pharmaceutical Industries Ltd (India), Sanofi Aventis LLC U.S (U.S.), RECORDATI (Italy), Mallinckrodt (U.S.), Hikma Pharmaceuticals PLC (Jordan), Abbott (U.S.), Avrio Health L.P (U.S.), Dr Reddy’s Laboratories Ltd (India), LNK INTERNATIONAL INC. (U.S.), Cipla Inc. (India), Aspen Pharmacare Australia Pty Ltd (Australia), Salix PHARMACEUTICAL (U.S.), Torrent Pharmaceuticals Ltd (India)

Market Opportunities

  • Growing Strict Government Regulations
  • High Technological Innovations

Market Definition

A laxative is a type of medicine that helps to resolve constipation or empty the bowel of fecal matter before procedures or surgery involving the lower bowel. Laxatives work by softening or loosening stool, increasing bowel movements, or promoting the contraction of the intestines to move stool through the bowel. They are available in various forms, including oral tablets, capsules, and suppositories, and can be used to treat both acute and chronic constipation.

Laxative Market Dynamics

Drivers                                                                                          

  • Increasing Prevalence of Gastrointestinal Disorders

Many individuals are adopting sedentary lifestyles and consume processed foods low in fiber, constipation rates rise, leading to a heightened demand for laxatives to manage these symptoms effectively. The growing burden of gastrointestinal issues underscores the necessity for accessible and effective treatment options, fueling the growth of the laxative market. Factors like poor diets, low fiber intake, insufficient hydration, and sedentary habits contribute to constipation, increasing the demand for laxatives to address associated symptom.

  • Growing Elderly Population

Elderly individuals are more susceptible to constipation and other gastrointestinal issues due to age-related changes in bowel function. As the geriatric population expands, particularly in developed countries, the demand for laxatives to manage these age-related digestive problems has increased significantly. The need for effective bowel health management strategies to address the unique needs of aging populations has become a key factor propelling the growth of the laxative market. This demographic shift underscores the importance of accessible and reliable laxative products to maintain digestive wellness among the elderly.

Opportunities

  • Increasing Healthcare Expenditure

As healthcare expenditure rises, particularly in emerging economies, it enhances access to healthcare services and medications like laxatives. This increased accessibility leads to greater affordability and availability of laxative products, driving market growth. The rising healthcare expenditure also reflects a growing recognition of the importance of digestive health, leading to increased demand for laxatives to manage gastrointestinal issues.

  • Changing Dietary Habits

Sedentary lifestyles and poor dietary choices, such as low fiber intake, inadequate hydration, and increased consumption of processed and low-nutrient foods, contribute to the prevalence of constipation. These dietary factors can further increase the risk of constipation by affecting stool consistency, bowel transit time, and overall gut health. As a result, the increasing prevalence of constipation due to changing dietary habits drives the demand for laxatives and related products in the market.

Restraints/Challenges

  • High Competition with Natural Remedies

The stiff competition from the growing popularity of natural remedies and alternative therapies for digestive health is increasing rapidly. Consumers are increasingly drawn to gentler, non-pharmacological solutions, leading to a shift in demand away from traditional laxatives. This trend reflects a broader preference for holistic approaches to wellness, challenging the market's reliance on conventional pharmaceutical products. As a result, the laxative market is impacted negatively by the growing interest in alternative solutions with fewer side effects.

  • High Cost of Drug Development

Pharmaceutical companies spend tens to hundreds of millions of dollars on drug development, which can be a substantial financial burden. This cost includes out-of-pocket expenses and capitalized costs over a long period, typically 10 years or more. The average cost per drug developed and approved by a single-drug company is around $350 million, while for companies that approve multiple drugs, the cost can be as high as $5.5 billion. These high costs can deter companies from developing new laxatives, limiting the market's growth potential.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In January 2020, Fresenius Kabi Austria GmbH launched a new website providing detailed information on the use of laxatives, including lactulose. This initiative aimed to increase awareness about lactulose among consumers, boost purchase power, enhance the product portfolio, and ultimately drive net sales. The website focused on the benefits and proper use of lactulose, a synthetic laxative used to treat constipation. This move was expected to positively impact the company's sales and customer engagement

Laxative Market Scope

The market is segmented on the basis of  type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Type

  • Osmotic laxatives
    • Osmotic laxatives with Electrolytes (Polyethylene Glycol)
      • Golytely
      • Colyte
      • Others 
    • Osmotic Laxatives without Electrolytes
      • Magnesium Hydroxide Solution
      • Epsom Salts
      • Lactulose
      • Others
  • Stimulant laxatives
    • Bisacodyl
    • Castor Oil
    • Senna
    • Phenolphthalein
    • Others
  • Bulk laxatives
    • Psyllium
    • Methyl Cellulose
    • Polycarbophil
    • Others
  • Lubricant and Emollient laxatives

Flavors

  • With Flavor
    • Fruit
    • Herbal
    • Others
  • Without Flavor

Source

  • Natural
    • Psyllium
    • Rhubarb
    • Senna
    • Slippery Elm
  • Synthetic
    • Phenolphthalein
    • Bisacodyl
    • Picosulfate
    • Oxyphenisatin
  • Others

Indication

  • Chronic Constipation
  • irritable bowel Syndrome with Constipation
  • Opioid-Induced constipation
  • Acute constipation
  • Others

Mode of Purchase

  • Prescription
  • Over-the-Counter

Dosage Form

  • Tablets
  • Capsules
  • Powder
  • Liquid and Gels
  • Suppositories
  • Others

Route of Administration

  • Oral
  • Rectal

Population Type

  • Children
  • Adults

Sales Channel

  • Hospitals
  • Elderly Care Centers
  • Home Healthcare
  • Pharmacy Stores
  • Grocery/Health and Beauty Stores
  • Others

Distribution channel

  • Direct Sales
  • Wholesalers
  • Others

North America Laxative Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country,  type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel as referenced above.

The market comprises the countries U.S., Canada and Mexico.   

U.S. dominates the market in both market share and revenue and is expected to maintain its dominance in the coming years. This growth is driven by increasing demand for gloves across various sectors and the market's rapid expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Laxative Market Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the global nursing homes and long-term care facilities market.

Some of the major players operating in the market are:

  • Boehringer Ingelheim International GmbH (Germany)
  • GlaxoSmithKline plc (U.K.)
  • Bayer AG (Germany)
  • Fresenius Kabi Austria GmbH (Austria)
  • Prestige Consumer Healthcare Inc. (U.S.)
  • Procter & Gamble (U.S.)
  • Sun Pharmaceutical Industries Ltd (India)
  • Sanofi Aventis LLC U.S (U.S.)
  • RECORDATI (Italy)
  • Mallinckrodt (U.S.)
  • Hikma Pharmaceuticals PLC (Jordan)
  • Abbott (U.S.)
  • Avrio Health L.P (U.S.)
  • Dr Reddy’s Laboratories Ltd (India)
  • LNK INTERNATIONAL INC. (U.S.)
  • Cipla Inc. (India)
  • Aspen Pharmacare Australia Pty Ltd (Australia)
  • Salix PHARMACEUTICAL (U.S.)
  • Torrent Pharmaceuticals Ltd (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The North America Laxative Market size will be worth USD 6.72 billion by 2031.
The North America Laxative Market growth rate will be 5.70% by 2031.
The Increasing Prevalence of Gastrointestinal Disorders and Growing Elderly Population are the growth drivers of the North America Laxative Market.
The type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel are the factors on which the North America Laxative Market research is based.
The major companies in the North America Laxative Market are Boehringer Ingelheim International GmbH (Germany), GlaxoSmithKline plc (U.K.), Bayer AG (Germany), Fresenius Kabi Austria GmbH (Austria), Prestige Consumer Healthcare Inc. (U.S.), Procter & Gamble (U.S.), Sun Pharmaceutical Industries Ltd (India), Sanofi Aventis LLC U.S (U.S.), RECORDATI (Italy), Mallinckrodt (U.S.), Hikma Pharmaceuticals PLC (Jordan), Abbott (U.S.), Avrio Health L.P (U.S.), Dr Reddy’s Laboratories Ltd (India), LNK INTERNATIONAL INC. (U.S.), Cipla Inc. (India), Aspen Pharmacare Australia Pty Ltd (Australia), Salix PHARMACEUTICAL (U.S.), Torrent Pharmaceuticals Ltd (India).
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials